FOX-04 – DRI 10mg
Investigated for its senolytic properties, this peptide disrupts FOXO4–p53 interactions to promote apoptosis in senescent cells, targeting aging and tissue regeneration pathways.
$110.00 $99.00
Category: Research Peptides
Brand:
In stock
FOX04-DRI (10mg) is a research peptide derivative engineered to modulate the interaction between FOXO4 and p53 proteins. By disrupting this binding pathway, FOX04-DRI has been studied for its potential role in selectively inducing apoptosis in senescent cells while sparing healthy cells.
This compound is utilized in advanced research exploring cellular aging, tissue regeneration, and age-associated biological mechanisms.
- Cellular senescence and apoptosis pathway studies
- Investigations into tissue regeneration and recovery mechanisms
- Research on age-related molecular pathways
- Studies examining FOXO4-p53 signaling and selective cell clearance
This product is intended strictly for laboratory research use only.
It is not for human consumption, diagnosis, treatment, or therapeutic use.
By purchasing, you confirm that this compound will be used exclusively for lawful scientific research purposes.
Additional Information:
- Purity: > 99.0% (HPLC)
- Form: Lyophilized powder
- Quantity: 10mg per vial
- Storage: Store at -20°C
- Shipping: Complies with all applicable research material regulations
Key Features:
- FOX04-DRI
- Quantity: 10mg per vial
- Molecular Formula: C252H386N64O71S2
- Molecular Weight: 5967.4 g/mol
- CAS Number: 2140476-02-5
This compound is not FDA-approved and is not intended to diagnose, treat, cure, or prevent any disease.
It is not a drug and is available only to qualified researchers age 21+ for laboratory research use only.
Related Products
Select options This product has multiple variants. The options may be chosen on the product page
10%$75.00 – $95.00Price range: $75.00 through $95.00
$67.50 – $85.50Price range: $67.50 through $85.50
